「日本人の食事摂取基準(2025年版)」策定検討会報告書 (425 ページ)
出典
公開元URL | https://www.mhlw.go.jp/stf/newpage_44138.html |
出典情報 | 「日本人の食事摂取基準(2025年版)」策定検討会報告書(10/11)《厚生労働省》 |
ページ画像
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
52) Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure.
DASH Collaborative Research Group. N Engl J Med. 1997;336(16):1117-1124.
53) Poorolajal J, Zeraati F, Soltanian AR, et al. Oral potassium supplementation for management of essential
hypertension: A meta-analysis of randomized controlled trials. PLoS One. 2017;12(4):e0174967.
54) Aburto NJ, Hanson S, Gutierrez H, et al. Effect of increased potassium intake on cardiovascular risk factors
and disease: systematic review and meta-analyses. BMJ. 2013;346(apr03 3):f1378.
55) Yang Q, Liu T, Kuklina EV, et al. Sodium and potassium intake and mortality among US adults: prospective
data from the Third National Health and Nutrition Examination Survey. Arch Intern Med.
2011;171(13):1183-1191.
56) Okayama A, Okuda N, Miura K, et al. Dietary sodium-to-potassium ratio as a risk factor for stroke,
cardiovascular disease and all-cause mortality in Japan: the NIPPON DATA80 cohort study. BMJ Open.
2016;6(7):e011632.
57) Cook NR, Obarzanek E, Cutler JA, et al. Joint effects of sodium and potassium intake on subsequent
cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med.
2009;169(1):32-40.
58) Kogure M, Hirata T, Nakaya N, et al. Multiple measurements of the urinary sodium-to-potassium ratio
strongly related home hypertension: TMM Cohort Study. Hypertens Res. 2020;43(1):62-71.
59) World Health Organization. Guideline: Potassium Intake for Adults and Children. World Health
Organization, Geneva; 2012.
60) Neal B, Wu Y, Feng X, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med.
2021;385(12):1067-1077.
61) Yin X, Rodgers A, Perkovic A, et al. Effects of salt substitutes on clinical outcomes: a systematic review
and meta-analysis. Heart. 2022;108(20):1608-1615.
62) Wang L, Manson JE, Buring JE, et al. Dietary intake of dairy products, calcium, and vitamin D and the risk
of hypertension in middle-aged and older women. Hypertension. 2008;51(4):1073-1079.
63) Ruidavets JB, Bongard V, Simon C, et al. Independent contribution of dairy products and calcium intake to
blood pressure variations at a population level. J Hypertens. 2006;24(4):671-681.
64) Behers BJ, Melchor J, Behers BM, et al. Vitamins and minerals for blood pressure reduction in the general,
normotensive population: A systematic review and meta-analysis of six supplements. Nutrients.
2023;15(19):4223.
65) Cormick G, Ciapponi A, Cafferata ML, et al. Calcium supplementation for prevention of primary
hypertension. Cochrane Database Syst Rev. 2021;8(8):CD010037.
66) Zhang X, Li Y, Del Gobbo LC, et al. Effects of magnesium supplementation on blood pressure: A metaanalysis of randomized double-blind placebo-controlled trials. Hypertension. 2016;68(2):324-333.
67) Rosanoff A, Costello RB, Johnson GH. Effectively prescribing oral magnesium therapy for hypertension:
A categorized systematic review of 49 clinical trials. Nutrients. 2021;13(1):195.
68) Ueshima H, Stamler J, Elliott P, et al. Food omega-3 fatty acid intake of individuals (total, linolenic acid,
long-chain) and their blood pressure: INTERMAP study. Hypertension. 2007;50(2):313-319.
69) Virtanen JK, Nyantika AN, Kauhanen J, et al. Serum long-chain n-3 polyunsaturated fatty acids,
415